Acetaminophen is generally safe at recommended doses, yet serious adverse reactions have been reported in susceptible adults. Individual susceptibility, influenced by nutritional status, alcohol exposure, age, and metabolic capacity, may modify responses and vulnerability to adverse effects. Experimental findings in mice indicate that doses considered therapeutic significantly alter important cellular signaling pathways, highlighting biological effects in the absence of overt toxicity. However, signaling alterations do not necessarily indicate injury, and their relevance to humans requires further investigation. This talk distinguishes therapeutic efficacy, molecular perturbation, and clinically meaningful harm, emphasizing individualized risk assessment and clearer definitions of safety during acetaminophen use.